David J. Grainger
42Patents
18h-index
18Co-inventors
74Inventor score
Filing activity: May 12, 1994 → Nov 4, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5733925A | Therapeutic inhibitor of vascular smooth muscle cells | Physics | 560 | Expired |
| US6074659A | Therapeutic inhibitor of vascular smooth muscle cells | Physics | 304 | Expired |
| US5811447A | Therapeutic inhibitor of vascular smooth muscle cells | Physics | 278 | Expired |
| US6117911A | Compounds and therapies for the prevention of vascular and non-vascular pathologies | Physics | 144 | Expired |
| US5770609A | Prevention and treatment of cardiovascular pathologies | Physics | 121 | Expired |
| US5595722A | Method for identifying an agent which increases TGF-beta levels | Physics | 87 | Expired |
| US6410587B1 | Compounds and therapies for the prevention of vascular and non-vascular pathologies | Physics | 61 | Expired |
| US5545569A | Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells | Physics | 60 | Expired |
| US5599844A | Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells | Physics | 49 | Expired |
| US5472985A | Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells | Physics | 43 | Expired |
| US5773479A | Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells | Physics | 37 | Expired |
| US5945456A | Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells | Physics | 36 | Expired |
| US6197789A | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues | Physics | 33 | Expired |
| US6262079A | Prevention and treatment of cardiovascular pathologies | Physics | 30 | Expired |
| US7084171B2 | Compounds and therapies for the prevention of vascular and non-vascular pathologies | Physics | 29 | Expired |
| US7238711B1 | Compounds and methods to inhibit or augment an inflammatory response | Human Necessities | 25 | Expired |
| US5847007A | Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells | Physics | 22 | Expired |
| US6251920A | Prevention and treatment of cardiovascular pathologies | Physics | 18 | Expired |
| US7511070B2 | Compounds and therapies for the prevention of vascular and non-vascular pathologies | Physics | 18 | Expired |
| US6989435B2 | Compounds and methods to inhibit or augment an inflammatory response | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6734208B2 | Compounds and therapies for the prevention of vascular and non-vascular pathologies | Physics | 12 | Expired |
| US6395494B1 | Method to determine TGF-&bgr; | Physics | 9 | Expired |
| US5998137A | Methods of diagnosis by detecting polymorphisms in the TGF-.beta.1 promoter | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7094550B2 | Method to determine TGF-beta | Physics | 6 | Expired |
| US7901873B2 | Methods for the diagnosis and treatment of bone disorders | Emerging Cross-Sectional Technologies | 5 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.